Ophthalmic Medical Education Summit: Enhancing Surgical Precision – Preoperative and Intraoperative Imaging Techniques
Katherine E. Talcott, MD, FASRS, Rishi P. Singh, MD, FASRS, and Dr. Gaurav K. Shah, MD, FASRS share how this imaging can be employed to navigate difficult retinal cases.
Katherine E. Talcott, MD, is a retinal surgeon at the Cole Eye Institute, Cleveland Clinic, in Cleveland. She is the associate residency program director and helped to develop and coordinate a new integrated PGY-1 and expansion from four to five residents per year. She is a consultant for Apellis, Eyepoint, and Genentech/Roche; receives grant support from Carl Zeiss Meditec and Regenxbio; and is on the Speaker’s Bureau for Genentech/Roche.
Rishi P. Singh, MD is the Chair of the Department of Ophthalmology at Mass General Brigham, overseeing ophthalmology across Massachusetts Eye and Ear, Massachusetts General Hospital, Brigham and Women’s Hospital, and affiliated sites. He is also a Professor of Ophthalmology at Harvard Medical School.
Previously, Dr. Singh served as Vice President and Chief Medical Officer at Cleveland Clinic Martin Health in Stuart, Florida, and as a staff surgeon at the Cleveland Clinic, where he was also Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio. He received both his undergraduate degree in medical science and his medical degree from Boston University, completing his internship at Tufts University. Dr. Singh went on to complete his ophthalmology residency at the Massachusetts Eye and Ear Infirmary/Harvard Medical School and a medical and surgical vitreoretinal fellowship at the Cole Eye Institute at the Cleveland Clinic.
Dr. Singh specializes in the management of complex retinal diseases, including diabetic retinopathy, retinal vein occlusions, retinal detachment, and age-related macular degeneration. He has authored over 300 peer-reviewed publications, books, and book chapters and serves as Principal Investigator for numerous national and international clinical trials aimed at improving outcomes for patients with retinal diseases.
He is the founder and past president of the Retina World Congress, chairs some of the largest continuing medical education meetings in retina, and serves on editorial boards and review panels for major ophthalmology journals. His leadership has extended into digital innovation, having helped lead enterprise-wide implementation of clinical technologies including Epic modules, digital informed consent, and patient-facing kiosks.
Dr. Singh has received multiple accolades for his contributions to ophthalmic research and innovation, including the Alpha Omega Alpha Research Award, the American Society of Retina Specialists Young Investigator Award, and the J. Donald Gass Beacon of Sight Award. He also leads The Center for Ophthalmic Bioinformatics, a research initiative focused on leveraging big data and artificial intelligence to advance understanding and treatment of retinal disease.
Dr. Shah completed medical school at the University of Illinois College of Medicine in Chicago. He was a resident at the University of Minnesota, Department of Ophthalmology for three years. His spent two years as a Heed Fellow at the renowned Wills Eye Hospital under the direction of Dr. William Benson. Dr. Shah came to the Barnes Retina Institute in the summer of 1999, where he not only sees patients in the office, but also teaches Washington University Ophthalmology residents and fellows and participates in Grand Rounds and various lecture forums. He was voted Ophthalmology Clinical Teacher of the Year for 2001-02.
Dr. Shah has published more than 187articles in ophthalmologic peer-reviewed journals, along with 19 book chapters. He has presented at the annual meeting of the American Academy of Ophthalmology, the American Society of Retina Specialist, the Retina Society, the Canadian Ophthalmology Society, and the Association for Research in Vision and Ophthalmology annual meeting. He has also lectured on various topics at most major meetings both inside and outside the United States.
Dr. Shah has received numerous awards, including the Heed Foundation Award, the Vitreous Society Honor Award, the American Academy of Ophthalmology Achievement Award, Senior Achievement Award, Lifetime Achievement Award and the American Society of Retina Specialists Senior Honor Award and Presidential Award. He has been or is currently an investigator in 30 clinical trials dealing with macular degeneration, diabetic retinopathy, uveitis and AIDS, and gene therapy. He serves as a reviewer for Archives of Ophthalmology, British Journal of Ophthalmology, Ophthalmic Surgery and Lasers, Retina, Graefe's Archive for Clinical and Experimental Ophthalmology, American Journal of Ophthalmology, and Ophthalmology, and is also an examiner for the American Board of Ophthalmology. Dr. Shah is a member of the Retina Society, ASRS, and Macula Society. Dr shah is also a OMIC Board member and member of the executive board at the asrs . He is currently Chief of Retina at CPMC in San Francisco and part of the Department of Ophthalmology. Dr Shah is currently part of the West Coast Retina Group in San Francisco
The Zeiss Professional Education Portal
Courses, videos, and whitepapers for the medically minded clinician.
Access Resources